A detailed history of Northern Trust Corp transactions in Albemarle Corp stock. As of the latest transaction made, Northern Trust Corp holds 1,119,470 shares of ALB stock, worth $107 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,119,470
Previous 1,165,044 3.91%
Holding current value
$107 Million
Previous $153 Million 30.33%
% of portfolio
0.02%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$92.77 - $135.46 $4.23 Million - $6.17 Million
-45,574 Reduced 3.91%
1,119,470 $107 Million
Q1 2024

May 14, 2024

SELL
$108.73 - $146.89 $3.7 Million - $5 Million
-34,035 Reduced 2.84%
1,165,044 $153 Million
Q4 2023

Feb 13, 2024

BUY
$113.26 - $170.8 $1.15 Million - $1.74 Million
10,165 Added 0.85%
1,199,079 $173 Million
Q3 2023

Nov 13, 2023

BUY
$162.63 - $243.44 $5.7 Million - $8.53 Million
35,019 Added 3.03%
1,188,914 $202 Million
Q2 2023

Aug 11, 2023

SELL
$172.91 - $232.22 $5.51 Million - $7.4 Million
-31,859 Reduced 2.69%
1,153,895 $257 Million
Q1 2023

May 15, 2023

SELL
$208.49 - $290.15 $5.83 Million - $8.12 Million
-27,970 Reduced 2.3%
1,185,754 $262 Million
Q4 2022

Feb 13, 2023

SELL
$214.02 - $325.38 $1.02 Million - $1.55 Million
-4,774 Reduced 0.39%
1,213,724 $263 Million
Q3 2022

Nov 14, 2022

SELL
$195.82 - $307.05 $3.12 Million - $4.89 Million
-15,933 Reduced 1.29%
1,218,498 $322 Million
Q2 2022

Aug 12, 2022

SELL
$187.76 - $270.92 $3.65 Million - $5.26 Million
-19,424 Reduced 1.55%
1,234,431 $258 Million
Q1 2022

May 13, 2022

SELL
$172.09 - $246.0 $1.91 Million - $2.73 Million
-11,079 Reduced 0.88%
1,253,855 $277 Million
Q4 2021

Feb 08, 2022

SELL
$214.16 - $283.8 $5.68 Million - $7.53 Million
-26,527 Reduced 2.05%
1,264,934 $296 Million
Q3 2021

Nov 15, 2021

BUY
$167.91 - $244.03 $1.96 Million - $2.85 Million
11,699 Added 0.91%
1,291,461 $283 Million
Q2 2021

Aug 13, 2021

SELL
$143.7 - $176.01 $2.39 Million - $2.92 Million
-16,611 Reduced 1.28%
1,279,762 $216 Million
Q1 2021

May 12, 2021

BUY
$140.69 - $185.25 $9.26 Million - $12.2 Million
65,829 Added 5.35%
1,296,373 $189 Million
Q4 2020

Feb 11, 2021

SELL
$86.73 - $149.91 $955,591 - $1.65 Million
-11,018 Reduced 0.89%
1,230,544 $182 Million
Q3 2020

Nov 16, 2020

SELL
$75.75 - $100.45 $914,984 - $1.21 Million
-12,079 Reduced 0.96%
1,241,562 $111 Million
Q2 2020

Aug 14, 2020

SELL
$52.7 - $86.74 $908,706 - $1.5 Million
-17,243 Reduced 1.36%
1,253,641 $96.8 Million
Q1 2020

May 14, 2020

BUY
$50.9 - $94.31 $2.6 Million - $4.82 Million
51,118 Added 4.19%
1,270,884 $71.6 Million
Q4 2019

Feb 14, 2020

BUY
$60.74 - $73.04 $38,812 - $46,672
639 Added 0.05%
1,219,766 $89.1 Million
Q3 2019

Nov 13, 2019

SELL
$59.3 - $75.53 $1.49 Million - $1.9 Million
-25,132 Reduced 2.02%
1,219,127 $84.8 Million
Q2 2019

Aug 13, 2019

BUY
$63.3 - $86.94 $2 Million - $2.75 Million
31,580 Added 2.6%
1,244,259 $87.6 Million
Q1 2019

May 13, 2019

SELL
$72.69 - $92.28 $3.67 Million - $4.65 Million
-50,431 Reduced 3.99%
1,212,679 $99.4 Million
Q4 2018

Feb 12, 2019

SELL
$73.13 - $107.99 $1.87 Million - $2.77 Million
-25,621 Reduced 1.99%
1,263,110 $97.3 Million
Q3 2018

Nov 14, 2018

BUY
$90.9 - $106.6 $6.73 Million - $7.89 Million
74,045 Added 6.1%
1,288,731 $129 Million
Q2 2018

Sep 18, 2018

SELL
$88.96 - $104.92 $639,533 - $754,269
-7,189 Reduced 0.59%
1,214,686 $115 Million
Q2 2018

Aug 14, 2018

SELL
$88.96 - $104.92 $760,608 - $897,066
-8,550 Reduced 0.69%
1,221,875 $115 Million
Q1 2018

May 09, 2018

SELL
$89.56 - $137.45 $3.52 Million - $5.4 Million
-39,321 Reduced 3.1%
1,230,425 $114 Million
Q4 2017

Feb 14, 2018

SELL
$127.48 - $144.58 $3.68 Million - $4.17 Million
-28,846 Reduced 2.22%
1,269,746 $162 Million
Q3 2017

Nov 13, 2017

BUY
$109.36 - $136.31 $142 Million - $177 Million
1,298,592
1,298,592 $177 Million

Others Institutions Holding ALB

About ALBEMARLE CORP


  • Ticker ALB
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 117,129,000
  • Market Cap $11.2B
  • Description
  • Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...
More about ALB
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.